245 related articles for article (PubMed ID: 2862944)
1. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
[TBL] [Abstract][Full Text] [Related]
2. The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
Smith GW; Hall JC; Farmer JB; Simpson WT
J Pharm Pharmacol; 1987 Aug; 39(8):636-41. PubMed ID: 2888855
[TBL] [Abstract][Full Text] [Related]
3. The effects of dopexamine on the cardiovascular system of the dog.
Brown RA; Farmer JB; Hall JC; Humphries RG; O'Connor SE; Smith GW
Br J Pharmacol; 1985 Jul; 85(3):609-19. PubMed ID: 4027482
[TBL] [Abstract][Full Text] [Related]
4. FPL 63012AR: a potent D1-receptor agonist.
Smith GW; Farmer JB; Ince F; Matu K; Mitchell PD; Naya I; Springthorpe B
Br J Pharmacol; 1990 Jun; 100(2):295-300. PubMed ID: 1974159
[TBL] [Abstract][Full Text] [Related]
5. Effects of prolonged infusion of dopexamine on beta 1- and beta 2-adrenoceptors in guinea-pig myocardium.
Williams DW; Elnatan J; Molenaar P; Summers RJ
J Auton Pharmacol; 1990 Jun; 10(3):127-37. PubMed ID: 1974255
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.
Martin SW; Broadley KJ
Br J Pharmacol; 1994 Jun; 112(2):595-603. PubMed ID: 7915614
[TBL] [Abstract][Full Text] [Related]
7. An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride).
Smith GW; O'Connor SE
Am J Cardiol; 1988 Aug; 62(5):9C-17C. PubMed ID: 2900602
[TBL] [Abstract][Full Text] [Related]
8. Presynaptic effects of dopexamine hydrochloride in the canine kidney.
Bass AS
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):33-6. PubMed ID: 1347154
[TBL] [Abstract][Full Text] [Related]
9. [Dopexamine: a new dopaminergic agonist].
Perrin G; Papazian L; Martin C
Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
[TBL] [Abstract][Full Text] [Related]
10. Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with alpha- and beta-adrenoceptors in vitro.
Ruffolo RR; Messick K; Horng JS
Naunyn Schmiedebergs Arch Pharmacol; 1984 Jul; 326(4):317-26. PubMed ID: 6090958
[TBL] [Abstract][Full Text] [Related]
11. SK&F 89124, a potent and selective agonist at prejunctional dopamine receptors.
Hieble JP; Sulpizio AC; Sarau HM; Flaim KE; Blumberg AL; McCafferty JP; Zeid RL
Fundam Clin Pharmacol; 1989; 3(6):621-42. PubMed ID: 2575569
[TBL] [Abstract][Full Text] [Related]
12. Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency.
Fitton A; Benfield P
Drugs; 1990 Feb; 39(2):308-30. PubMed ID: 1970288
[TBL] [Abstract][Full Text] [Related]
13. Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.
Böhm M; Pieske B; Schnabel P; Schwinger R; Kemkes B; Klövekorn WP; Erdmann E
J Cardiovasc Pharmacol; 1989 Oct; 14(4):549-59. PubMed ID: 2478768
[TBL] [Abstract][Full Text] [Related]
14. Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride.
Goldberg LI; Bass AS
Am J Cardiol; 1988 Aug; 62(5):37C-40C. PubMed ID: 2841837
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Uptake1 by dopexamine hydrochloride in vitro.
Mitchell PD; Smith GW; Wells E; West PA
Br J Pharmacol; 1987 Oct; 92(2):265-70. PubMed ID: 2890392
[TBL] [Abstract][Full Text] [Related]
16. Human renovascular effects of dopexamine hydrochloride: a novel agonist of peripheral dopamine and beta 2-adreno-receptors.
Magrini F; Foulds R; Roberts N; Macchi G; Mondadori C; Zanchetti A
Eur J Clin Pharmacol; 1987; 32(1):1-4. PubMed ID: 2884113
[TBL] [Abstract][Full Text] [Related]
17. The DA1 receptor agonist fenoldopam (SK & F 82526) is also an alpha 2-adrenoceptor antagonist.
Ohlstein EH; Zabko-Potapovich B; Berkowitz BA
Eur J Pharmacol; 1985 Dec; 118(3):321-9. PubMed ID: 2867915
[TBL] [Abstract][Full Text] [Related]
18. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs.
Neustein SM; Dimich I; Sampson I; Sadeghi A; Mezrow C; Shiang H
Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210
[TBL] [Abstract][Full Text] [Related]
19. Effect of dopexamine hydrochloride on sympathetic neuroeffector transmission in rabbit isolated pulmonary artery.
Nedergaard OA
Pharmacol Toxicol; 1996 Mar; 78(3):161-6. PubMed ID: 8882349
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney.
Bass AS
J Pharmacol Exp Ther; 1990 May; 253(2):798-802. PubMed ID: 1971021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
